Digest ++
Digest ++, licence 80092941: active licence in Health Canada data. The French and European references below do not constitute authorisation for sale in France or an assessment of safety or efficacy.
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
Natural health product licensed in Canada
- Licence holder
- Dr. Ma's Laboratories Inc.
- NPN or DIN-HM
- 80092941
- Status
- Active licence
- Licence date
- 19 June 2019
- Revision date
- Not provided
- Form
- Capsule, dur
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Protéase Source : Aspergillus niger - En entier | 70.0 milligramme | Not calculated |
| 4-alpha-D-glucane glucanohydrolase Source : Aspergillus niger - En entier | 140.0 milligramme | Not calculated |
| Bromélaïne de fruit Source : Ananas comosus var bracteatus - fruit | 100.0 FCC PU | Not calculated |
| Bromélaïne de fruit Source : Ananas comosus var bracteatus - fruit | 40.0 milligramme | Not calculated |
| bêta-galactosidase Source : Aspergillus flavus var. oryzae - En entier | 3900.0 FCC ALU | Not calculated |
| bêta-galactosidase Source : Aspergillus flavus var. oryzae - En entier | 30.0 milligramme | Not calculated |
| 4-(1,3;1,4)-bêta-D-glucane 4-glucanohydrolase Source : Aspergillus niger - En entier | 3500.0 FCC CU | Not calculated |
| 4-(1,3;1,4)-bêta-D-glucane 4-glucanohydrolase Source : Aspergillus niger - En entier | 20.0 milligramme | Not calculated |
| Protéase Source : Aspergillus niger - En entier | 1800.0 FCC SAPU | Not calculated |
| 4-alpha-D-glucane glucanohydrolase Source : Aspergillus niger - En entier | 22000.0 FCC DU | Not calculated |
Non-medicinal ingredients
Stéarate de magnésium, Hypromellose, cellulose
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | minimum: 19.0 Année(s) | 1.0 Capsule | 1.0 Tous les jours |
Uses authorised in Canada
Acts as a digestive aid.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Warnings are available in English on the official record.
Source
Official Health Canada record, licence 80092941
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.